Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds

J Enzyme Inhib Med Chem. 2016 Dec;31(6):1306-11. doi: 10.3109/14756366.2015.1128427. Epub 2016 Jan 8.

Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the fundamental reaction of CO2 hydration in all living organisms, being actively involved in the regulation of a plethora of patho/physiological conditions. A series of benzothiazole-based sulfonamides were synthesized and tested as possible CA inhibitors. Their inhibitory activity was assessed against the cytosolic human isoforms hCA I and hCA II and the transmembrane hCA IX and hCA XII. Several of the investigated derivatives showed interesting inhibition activity and selectivities for inhibiting hCA IX and hCA XII over the off-target ones hCA I and hCA II. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds, within the active site of hCA IX.

Keywords: Benzothiazole sulfonamides; carbonic anhydrase; docking; metalloenzyme; molecular dynamic simulations.

MeSH terms

  • Benzothiazoles / chemistry*
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Carbonic Anhydrases / drug effects*
  • Isoenzymes / antagonists & inhibitors*
  • Molecular Docking Simulation
  • Sulfonamides / chemistry*

Substances

  • Benzothiazoles
  • Carbonic Anhydrase Inhibitors
  • Isoenzymes
  • Sulfonamides
  • Carbonic Anhydrases
  • benzothiazole